You call the valuation ridiculous but likely haven't and won't do a valuation yourself on how much AVXL should be valued if it's drug is approved in Europe and/or USA / Rest of world. Until you do such a valuation and show the workings I'm not gonna take you very seriously in calling it a "ridiculous valuation", at-least Mayo has done a calc and showed his workings.
Market Data 
Markets 
